Cisplatin clearance
WebAug 31, 2024 · The recommended dose of ALIMTA when administered with cisplatin for initial treatment of locally advanced or metastatic non-squamous NSCLC in patients with a creatinine clearance (calculated by Cockcroft-Gault equation) of 45 mL/min or greater is 500 mg/m 2 as an intravenous infusion over 10 minutes administered prior to cisplatin on … WebSep 21, 2016 · In 25 patients assessable for both courses, the use of a fixed dose of cisplatin resulted in reduced exposure to unbound platinum in patients at the upper extremes of BSA (P = .003) and higher exposures in patients at the lower extremes (P = .009), as compared with exposures following the BSA-adjusted dose.Although clearance …
Cisplatin clearance
Did you know?
WebMar 9, 2024 · Currently, societies of nephrology recommend dose reductions in cisplatin for patients with renal insufficiency of creatinine clearance (CrCl) between 30 and 60 mL/min. 10-12 Among their recommendations, unified protocol based on Kintzel's indication is especially popular. 10, 11, 13 Kintzel et al reported an indicator of cisplatin dose ...
WebFeb 16, 2016 · All patients were treated with high-dose cisplatin CCRT. The main outcome parameters were nephrotoxicity (defined as creatinine clearance grade 2 or more) and cumulative doses of cisplatin and radiation. Results: 133 patients (64%) completed all pre-planned courses of cisplatin. Nephrotoxicity was the main reason to discontinue the … WebBACKGROUND: Cisplatin-based chemotherapy is the first-line (1L) treatment for eligible patients with locally advanced/metastatic urothelial carcinoma (mUC). However, many patients with mUC are ineligible for cisplatin-based therapy due to age- or dis ... These considerations included renal impairment (creatinine clearance <60 mL/min ...
WebApr 15, 2003 · It is noteworthy that cisplatin dose (in the range 70–80 mg m −2) was not associated with nephrotoxicity and that baseline creatinine clearance did not predict for nephrotoxicity (defined as ... WebFigure 2. Suggested pathways of cisplatin trafficking in the cochlea. The major entry route for cisplatin entry into the cochlea is via the blood-strial barrier into the stria vascularis, and clearance into the endolymph from the stria vascularis prior to entry into hair cells across their apical membrane.
WebOct 1, 2024 · Cisplatin is a potent chemotherapeutic used for the treatment of many types of cancer. However, its dose-limiting side effect is nephrotoxicity leading to acute kidney injury (AKI). ... In addition, mice and humans differ in their rate of cisplatin clearance. The peak plasma concentration of cisplatin is 2.4–20 times greater in mice than in ...
WebJun 19, 2024 · This work allows us to appreciate the evolution of cisplatin clearance during the first weeks of age. Interestingly, our patient had a cisplatin CL on cycle 1 which was markedly lower than the CL observed in another previously treated 2-week-old baby (2.9 mL/min/kg compared to 10.6 mL/min/kg [ 6 ]), highlighting the differences in ... logan second hand constantaWebCisplatin dose adjustment in patients with renal impairment must be improved. Estimating GFR with the aMDRD formula and adding an intermediary level of dose reduction for … induction nscsWebSCLC – Cisplatin-Etoposide IV ... the cisplatin with carboplatin AUC 6 for a calculated creatinine clearance or AUC 5 for an EDTA clearance. Version 1.1 (Dec 2013) Page 4 of 7 SCLC – Cisplatin-Etoposide IV Regimen 21 day cycle for 4 cycles Drug Dose Days Administration Cisplatin 225mg/m 1, 2, 3 Intravenous infusion in 1000ml ... logan second handWebFor research use only. Cisplatin (NSC 119875, Cisplatinum, cis-diamminedichloroplatinum II, CDDP, cis DDP, DDP) is an inorganic platinum complex, which is able to inhibit DNA synthesis by conforming DNA … induction ntuWebSep 18, 2024 · Cisplatin can be used as monotherapy or as part of a multi-drug regimen. Patients should have proper hydration while monitoring urine output before, during, and for 24 hours following administration. Renal … logan second r rated superheroWebCisplatin is a clinically advanced and highly effective anticancer drug that is used for the treatment of various solid tumors, such as lung cancer, stomach cancer, and ovarian cancer [ 1 ].... induction nucleophilicWebThe effect is dose-dependent at oral doses between 600 and 1800 mg/day in patients with normal kidney clearance. 66 ESRD patients may require higher doses (5 mg) and several studies have provided NAC intravenously to these … logan sectional